Claritev Corporation (CTEV)

Market Cap	478.25M
Revenue (ttm)	951.00M
Net Income (ttm)	-341.68M
Shares Out	16.53M
EPS (ttm)	-20.90
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	207,136
Open	30.01
Previous Close	31.21
Day's Range	28.34 - 30.90
52-Week Range	11.70 - 74.07
Beta	0.52
Analysts	Buy
Price Target	60.67 (+109.64%)
Earnings Date	Feb 24, 2026

About CTEV

Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1980
• Employees: 2,700
• Stock Exchange: NYSE
• Ticker Symbol: CTEV
• Website: https://www.claritev.com

Financial Performance

In 2024, Claritev's revenue was $930.62 million, a decrease of -3.21% compared to the previous year's $961.52 million. Losses were -$1.65 billion, 1694.9% more than in 2023.

Analyst Summary

According to 3 analysts, the average rating for CTEV stock is "Buy." The 12-month stock price target is $60.67, which is an increase of 109.64% from the latest price.

Price Target

$60.67

(109.64% upside)

Analyst Consensus: Buy